IQI
BMY icon

Integrated Quantitative Investments’s Bristol-Myers Squibb BMY Stock Holding History

Integrated Quantitative Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$599K Buy
+9,872
New +$575K 0.11% 257
2025
Q4 		– Sell
-5,900
Closed -$266K – 410
2025
Q3 		$266K Sell
5,900
-4,790
-45% -$224K 0.08% 282
2025
Q2 		$495K Buy
+10,690
New +$525K 0.15% 219
2025
Q1 		– Sell
-7,000
Closed -$396K – 291
2024
Q4 		$396K Buy
+7,000
New +$391K 0.2% 149

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integrated Quantitative Investments's BMY Position: Q1 2026 in Review

Integrated Quantitative Investments opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 9,872 shares worth $599K. The stake represents 0.11% of the portfolio and ranks #257 among its holdings. This is a return to the name: Integrated Quantitative Investments previously reported a position in BMY as recently as Q3 2025.

Integrated Quantitative Investments first reported a position in BMY in Q4 2024 and has held it in 4 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Integrated Quantitative Investments held 9,872 shares of Bristol-Myers Squibb worth $599K as of Q1 2026.
  • Bristol-Myers Squibb was a new Integrated Quantitative Investments position in Q1 2026.
  • Bristol-Myers Squibb made up 0.11% of Integrated Quantitative Investments's portfolio in Q1 2026, its #257 holding.
  • Integrated Quantitative Investments first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 4 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.